GLPwatch
Papers (12034)
Page 150 of 201, ranked by citation count.
- GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.
- [Potentiation of weight reduction with GLP-1 receptor agonists].
- Fabrication and Preclinical Evaluation of Hyaluronic Acid/Aminoclay Nanocomposite Microneedles for Noninvasive Delivery of Semaglutide in Anti-Obesity Therapy.
- The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort.
- Tirzepatide for Obesity Treatment and Diabetes Prevention.
- [Successful treatment with liraglutide in type 1 diabetes and MODY].
- [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
- Long-term efficacy of daily oral semaglutide as add-on or switch therapy in adults with type 2 diabetes: a 12-month real-world retrospective study.
- Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report.
- The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Subocclusive ileus following off-label high-dose semaglutide use.
- Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes.
- Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes.
- Is liraglutide safe and effective in the elderly obese patients?: A single center experience.
- Molecular dynamics insights into the binding interactions of semaglutide with human serum albumin.
- GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
- Ethical Considerations in the Use of Weight Loss Medications.
- Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.
- Glucagon-like peptide-1 receptor agonists: a review of the literature from a dental perspective.
- A LEADER in the management of type 2 diabetes and cardiorenal disease.
- Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis.
- Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
- Evaluation of Pre-Treatment Assessment of Semaglutide Users: Balancing the Benefits of Weight Loss vs. Potential Health Consequences.
- New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report.
- Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.
- Evaluating the efficacy and safety of survodutide for obesity: a systematic review and meta-analysis of randomized controlled trials.
- Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis.
- Incretin-based therapy for type 2 diabetes mellitus: pancreatic and extrapancreatic effects.
- Cancer prevention and interception with antidiabetic and anti-obesity drugs: Current and future perspectives.
- Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity-Reply.
- Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States.
- Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method.
- Antidiabetic drugs in Parkinson's disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation.
- Influence of GLP1 receptor rs6923761 and rs761387 genetic variants on oral semaglutide response in patients with type 2 diabetes.
- Editorial commentary: Weight loss for cardiovascular disease prevention - is semaglutide the answer?
- Exendin-4 intervention attenuates atherosclerosis severity by modulating myeloid-derived suppressor cells and inflammatory cytokines in ApoE<sup>-/-</sup> mice.
- Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
- Diagnostic Performance of Exendin-4 PET/CT in Localizing Insulinomas: A Systematic Review and Meta-analysis.
- The prostaglandin E<sub>2</sub> EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity.
- Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management.
- Gateways to clinical trials.
- Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review.
- Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane following Exposure to Semaglutide.
- [Why is a combination of basal insulin with a GLP-1 receptor agonist useful in many patients with type 2 diabetes?]
- Semaglutide and MASH resolution: A pooled analysis of recent trials.
- Semaglutide in Heart Failure With Preserved Ejection Fraction: Emerging Evidence and Clinical Implications.
- Liraglutide innovations: a comprehensive review of patents (2014-2024).
- <sup>68</sup>Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication.
- [Contribution of metabolic sensors on feeding behaviour and the control of body weight].
- Cardiovascular safety of liraglutide for the treatment of type 2 diabetes.
- Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge.
- Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials.
- Exenatide implant therapy in diabetes.
- M14 substitutions in exanatide modulate alpha-synuclein aggregation.
- Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies.
- Possible dulaglutide-associated cholecystitis with safe continuation post cholecystectomy.
- Patient experiences with liraglutide for obesity and binge eating disorder-A qualitative study.
- Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Efficacy and Safety of Pharmacological, Endoscopic, and Surgical Treatments for Obesity: A GRADE-Based Network Meta-Analysis.
- Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties.